See also this year's filing and all EDGAR filings for this company.
PDF Report 0001311596_2016_Tobira_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001311596, Tobira Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 63,251,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 400,000 |
| 3 | remainder_Assets | 1,818,000 |
| 4 | LiabilitiesCurrent | 7,423,000 |
| 5 | LiabilitiesNoncurrent | 15,074,000 |
| 6 | remainder_Liabilities | 201,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,871,000 |
| 9 | ResearchAndDevelopmentExpense | 24,672,000 |
| 10 | remainder_Expenses | 14,074,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 65,469,000 |
| 1 | Liabilities | 22,698,000 |
| 2 | Expenses | 49,617,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 42,771,000 |
| 5 | NetIncome | -49,617,000 |
| 6 | ComprehensiveNetIncome | -49,617,000 |
| 7 | BaseVar | 68,892,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.990 |
| 9 | EconomicCapitalRatio | 2.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
